GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDING CO., LTD.

Otros idiomas Guangzhou Baiyunshan Pharmaceutical Holding Co., Ltd.

Acciones

874 CNE100000387

Diferido Hong Kong S.E. Otros sitios de cotización 04:12:10 03/05/2024			Varia. Cinco días.	Varia. 1 de enero.
21,45 ^HKD	-2,05 %		+4,63 %	-1,38 %

26/04	Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited presenta los resultados del primer trimestre finalizado el 31 de marzo de 2024	CI
15/03	Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited informa de los resultados de ganancias para el año completo finalizado el 31 de diciembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	26/04
Baiyunshan Pharmaceutical's 2023 Profit Rises 2%	18/03
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Announces Final Ordinary Dividend for the Year Ended 31 December 2023	15/03
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	15/03
Baiyunshan Pharma's Unit Gets Green Light to Produce Hepatitis B Drug	01/03
Guangzhou Pharma Unit Gets Green Light to Trial Oral Liquid Drug	09/02
Guangzhou Baiyunshan Pharmaceutical Arm Floats 1 Billion Yuan Biomedical VC Fund	19/12
Guangzhou Baiyunshan Pharmaceutical Ends Spin-Off Plans, Seeks China Listing for Subsidiary	19/12
Guangzhou Pharma Expands Scope of Drug Production License	13/11
Guangzhou Baiyunshan Pharmaceutical's Profit Up 11% in Q3	30/10/23
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23
Baiyunshan Pharmaceutical Reports Increase in H1 Attributable Profit	13/09/23
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023	17/08/23
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(SHSE:600332) added to Shanghai Stock Exchange 180 Value Index	12/06/23
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(SHSE:600332) added to SSE 180 Index	12/06/23
Guangzhou Pharma Registers Pain-Relief, Anti-Inflammatory Drugs in Russia	26/05/23
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the First Quarter Ended March 30, 2023	27/04/23
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Announces Election of the Supervisor Representing the Employees of the 9th Session of the Supervisory Committee	25/04/23
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Announces Final Dividend for the Year Ended 31 December 2022	17/03/23
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022	17/03/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Guangzhou Baiyunshan Pharmaceutical Holding Co., Ltd.

Acciones

874

CNE100000387

Otros idiomas

Filtros